SG Americas Securities
PLSE icon

SG Americas Securities’s Pulse Biosciences PLSE Stock Holding History

SG Americas Securities’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,110
Closed -$193K – 3685
2024
Q4 		$193K Buy
+11,110
New +$196K ﹤0.01% 2192
2021
Q4 		– Sell
-4,717
Closed -$102K – 3717
2021
Q3 		$102K Buy
+4,717
New +$101K ﹤0.01% 3662

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SG Americas Securities's PLSE Position: Q1 2025 in Review

SG Americas Securities sold out of Pulse Biosciences (PLSE) in Q1 2025, closing a stake of 11,110 shares — an estimated $193K sold.

SG Americas Securities first reported a position in PLSE in Q3 2021 and held it in 2 quarters. The position peaked at $193K in Q4 2024. 84 funds tracked by Wall St. Rank hold PLSE as of Q1 2025.

  • SG Americas Securities reported no remaining Pulse Biosciences position as of Q1 2025 after selling out during the quarter.
  • SG Americas Securities sold 11,110 Pulse Biosciences shares in Q1 2025, an estimated $193K.
  • SG Americas Securities first reported a position in Pulse Biosciences in Q3 2021 and held it in 2 quarters.
  • SG Americas Securities's Pulse Biosciences position peaked at $193K in Q4 2024.
  • 84 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2025.

Based on SG Americas Securities's 13F filing for Q1 2025, filed 15 Apr 2025.